Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease

Young H. Sung, Sun Ju Chung, Sung Reul Kim, Myoung C. Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)


We aimed to evaluate the clinical factors predicting response to dopaminergic treatment for resting tremor in patients with Parkinson's disease (PD). Eighty-five PD patients with prominent resting tremor, defined as tremors of score greater than 3 in at least one limb on the Unified Parkinson's Disease Rating Scale (UPDRS), were divided into those responsive or nonresponsive to dopaminergic treatment. Responsiveness was defined as a reduction of at least two points for more than 3 months in the UPDRS tremor score. Of the 85 patients, 36 (42.4%) were responsive and 49 (57.6%) were nonresponsive to dopaminergic treatment Initial UPDRS III score (P = 0.015) and Hoehn and Yahr stage (P = 0.010) were each significantly higher in the RG than in the NRG. UPDRS subscores for rigidity (P = 0.012), bradykmesia (P = 0.021) and postural impair ment (P = 0.018) also correlated with responsiveness to dopaminergic treatment Resting tremor in PD patients was more responsive to dopaminergic treatment when accompanied by moderate degrees of bradykinesia and rigidity than in patients without other prominent parkinsonian features.

Original languageEnglish
Pages (from-to)137-140
Number of pages4
JournalMovement Disorders
Issue number1
Publication statusPublished - 2008 Jan 15
Externally publishedYes



  • Bradykinesia
  • Dopaminergic treatment
  • Parkinson's disease
  • Resting tremor
  • Rigidity

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this